MRTX1133 is a highly selective, first-in-class inhibitor of KRAS G12D. MRTX1133 targets the KRAS G12D protein in both active and inactive states. MRTX1133 selectively inhibits KRAS G12D mutant, but not KRAS wild-type, tumor cells[1][2].
Molecular Weight:
646.67
Formula:
C34H33F3N6O4
Target:
Others|||Ras|||Kras
T37130
* VAT and and shipping costs not included. Errors and price changes excepted